Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel analgesic/antiinflammatory agents from Sanwa Shoyaku

Jan. 7, 1997

Cephalon files first NDA submission

Jan. 3, 1997

Cambridge NeuroScience/Gladstone Institute AD collaboration

Jan. 3, 1997

German investigators present potent dopamine D1 antagonist

Jan. 3, 1997

Nippon Zoki claims aFGF fragments for CNS indications

Jan. 3, 1997

Debate centers on the safety of coated aspirin

Jan. 2, 1997

Antidementia agents reported by Eisai

Jan. 2, 1997

Novel anticonvulsant approved by FDA

Dec. 31, 1996

Japanese researchers describe analgesic tripeptides

Dec. 31, 1996

First phase II results for Innapharma's peptide antidepressant

Dec. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...